Clinical Trials
Pfizer and BioNTech Announce Positive Topline Results From Pivotal...
Pfizer Inc. and BioNTech SE announced results from a Phase 2/3 trial showing a favorable safety profile and robust neutralizing antibody responses in children 5...
Clinical Trials
Valneva Completes Recruitment of Elderly Participants in Phase 3...
Valneva SE, a specialty vaccine company, announced that it has completed recruitment of the initial cohort of elderly participants in Valneva’s Phase 3 trial, VLA2001-304,...
Clinical Trials
RedHill Biopharma Reports Top-Line Data from Opaganib Phase 2/3...
RedHill Biopharma Ltd. , a specialty biopharmaceutical company, announced preliminary top-line data from the 475-patient global Phase 2/3 study with opaganib (ABC294640) in hospitalized patients...
Articles
Why real-world data is helping us overcome the shortcomings...
Karen Ooms at Quanticate explains why clinical trial data alone is not enough to truly understand a drug’s effectiveness and argues that real-world data (RWD)...
Clinical Trials
Medrio and PHASTAR Unite to Offer Data Visualization for...
Medrio, Inc. a leading provider of decentralized and eClinical technology to pharmaceutical, biotech, medical device, diagnostics, and animal health markets and PHASTAR, a global specialist...
Clinical Trials
LTO Network and Sphereon Partner With Triall for World’s...
Dutch blockchain companies LTO Network and Sphereon have partnered with Triall, experts in the realm of blockchain and clinical research, to deliver the first COVID-19...
Clinical Trials
Reliance obtains DCGI approval to conduct Phase I Covid-19...
Reliance Life Sciences has obtained approval from the Drugs Controller General of India (DCGI) to carry out a Phase I clinical trial of its Covid-19...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.